• A private hospital in Chennai has successfully performed a bone marrow transplant on a 12-year-old girl suffering from Bloom Syndrome, a rare inherited genetic disorder.
• The transplant used stem cells from her younger brother, offering new hope in managing complications of the disease.
• Bloom Syndrome, also known as Bloom-Torre-Machacek syndrome or congenital telangiectatic erythema, is caused by mutations in the BLM gene.
• This gene plays a critical role in maintaining DNA structure and repairing damaged DNA. When faulty, it leads to abnormal cell growth, delayed development, immune deficiencies, sensitivity to sunlight, and a significantly increased risk of cancer.
• The disorder is inherited in an autosomal recessive pattern, with higher prevalence observed among the Ashkenazi Jewish population.
• Children with Bloom Syndrome often present with stunted growth, distinct facial features, recurrent infections, diabetes risk due to insulin resistance, and fertility issues in adulthood.
• While there is no definitive cure, treatment focuses on symptom management through a multidisciplinary approach.
• The successful bone marrow transplant in Chennai represents a milestone in the treatment of Bloom Syndrome in India, potentially opening new avenues for improved quality of life for patients.